v3.26.1
Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($)
$ in Millions
Total
Common stock
Additional paid-in capital
Accumulated other comprehensive loss
Accumulated deficit
Balance at beginning of period (in shares) at Dec. 31, 2024   265,000,000      
Balance at beginning of period at Dec. 31, 2024 $ 2,557 $ 3 $ 5,194 $ (47) $ (2,593)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Total comprehensive income 50       50
Stock-based compensation activity (in shares)   1,000,000      
Stock-based compensation activity (9)   (9)    
Cash dividend (24)   (24)    
Repurchases of common stock (3)   (3)    
Balance at end of period (in shares) at Mar. 31, 2025   266,000,000      
Balance at end of period at Mar. 31, 2025 $ 2,571 $ 3 5,158 (47) (2,543)
Balance at beginning of period (in shares) at Dec. 31, 2025 265,822,404 266,000,000      
Balance at beginning of period at Dec. 31, 2025 $ 2,730 $ 3 5,083 (41) (2,315)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Total comprehensive income 61     (1) 62
Stock-based compensation activity 7   7    
Cash dividend (24)   (24)    
Repurchases of common stock $ (4)   (4)    
Balance at end of period (in shares) at Mar. 31, 2026 265,965,593 266,000,000      
Balance at end of period at Mar. 31, 2026 $ 2,770 $ 3 $ 5,062 $ (42) $ (2,253)